top of page

Curing blindness with regenerative cell therapies

StemSight develops off-the-shelf cell therapies for unmet medical needs in corneal blindness.
OPTION 1.jpg

EIT Health Catapult Biotech pitching competition 2022-2023

Tech Tour's flagship event for Europe's most innovative companies

"The most innovative startup in health and life sciences in Europe"


About us

StemSight's founder team is composed of top scientists in the field of regenerative medicine and tissue engineering for eye applications. Our scientific excellence is complimented by global business experience of our board and advisors.

Latest news


Meet us at LSX World Congress in London!

Our CEO Laura will be attending the LSX World Congress in London on May 3-4. Seek us out through the partnering platform or send us an email for catching up!


EIT Health Catapult Semifinals pitches online!

The Biotech category semifinalist pitches are now live on the EIT Health Catapult platform on-demand. Register here for free to see all the pitches. The finalists will be announced later in the Spring, and the top companies will present live at the Bits and Pretzels Healthtech event in Munich in June.


StemSight one of EIT Health Catapult finalists!

StemSight has been selected as one of the three finalists in Biotech category for the EIT Health Catapult competition and training program. The finals will be held in Munich on the 20th of June at the Bits & Pretzels Healthtech. 


Laura Koivusalo one of the Ten Outstanding Young Persons of the World

The global Junior Chamber International organization selects StemSight CEO Laura among this year's Ten Outstanding Young Persons of the World. Amazing news!

Want to know more?

Interested to hear about our most recent updates, upcoming milestones and investment opportunities? Have an potential collaboration idea? Just thought of someone we absolutely need to meet to help us along?


Send us a message!

logo_stemsight_slogan uusi kirjoitusasu_white text_no background.png
bottom of page